Sign in
Taking people in United StatesNo phase

Hearing devices and how well adults with hearing loss understand speech

Compares hearing instrument models for speech understanding and listening effort in adults with hearing loss.

Key facts

Who runs it
Sonova AG
Where
Tampa, United StatesSee the site
Trial code
Registry title
Speech Understanding and Listening Effort Benefits of Hearing Instruments
Status
Recruiting
People taking part
30 people, planned
Started
5 Feb 2025
Planned end
Dec 2025
Type of study
Interventional
Treatments tested
  • hearing instruments
Record updated
11 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with hearing loss in both ears who already use hearing aids. They will test different hearing instrument models in the lab.

Age
18 to 95 years
Sex
All sexes
Disease stage
N3 or N4 hearing loss, in both ears.
Earlier treatment
Must be an experienced hearing aid user.

Main reasons for not taking part

  • Hearing within normal limits, or hearing not fit for the hearing instruments under study
  • Not able to read, write or speak English
  • Not able to complete complex listening tasks
  • Belonging to a vulnerable population
  • Age outside 18 to 95 years

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adult 18-95 years
  • N3 or N4 hearing loss
  • Experienced hearing aid user
  • English fluency
  • Cognitively able to complete complex listening tasks

Who cannot take part

  • Outside of specified age range
  • Vulnerable populations
  • Hearing within normal limits or otherwise not appropriate for hearing instruments under study
  • Inability to read, write, or speak English
  • Inability to complete complex listening tasks

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 95 years old?

Where in United States

  • University of South Florida Auditory Neurosciences & Technology LabTampa, United StatesContact: Study CoordinatorTaking people

About the trial

What the trial wants to find out

The goal of this clinical study is to investigate the benefits of hearing instrument use in adults with hearing loss. The main questions it aims to answer are:

Read full original descriptionShow less

Does hearing instrument use improve speech understanding and listening effort amount people with hearing loss? Researchers will compare varying models of hearing instruments to see how speech understanding and listening effort are impacted.

Participants will be asked to wearing varying hearing instruments and participate in lab-based activities to evaluate their speech understanding, listening effort, and subjective preference.

The group in the trial

  • Hearing instrument usersTreatment being tested

    Individuals with hearing impairment will be fit with three different models of hearing instruments. They will all be fit with the same hearing instruments, although they will not be aware which model they are using at the time of testing.

    Treatment: hearing instruments

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Speech Understanding and Listening Effort Benefits of Infinio Sphere
Plain-language title
Hearing devices and how well adults with hearing loss understand speechGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07116135, who can take part
Record updated
11 August 2025